1-19 of 19
Authors: Douglas B Johnson
Save search
Sort by
Journal Article

Steroid-refractory immune mediated hepatitis managed with budesonide in patients with metastatic melanoma: proof of concept and literature review Open Access

PDF
Roma A Kankaria and Douglas B Johnson
The Oncologist, Volume 30, Issue 1, January 2025, oyae361, https://doi.org/10.1093/oncolo/oyae361
Published: 20 January 2025
Journal Article

Management of severe immune-related adverse events and outcomes in patients with advanced non-small cell lung cancer receiving immune checkpoint inhibitors Open Access

PDF
Jarushka Naidoo and others
The Oncologist, oyae318, https://doi.org/10.1093/oncolo/oyae318
Published: 20 November 2024
Journal Article

Prognostic Risk Stratification and End-of-Life Care Outcomes in Patients With Metastatic Melanoma Treated With Immune Checkpoint Inhibitors Open Access

PDF
Robert N Grad and others
The Oncologist, Volume 28, Issue 10, October 2023, Pages 911–916, https://doi.org/10.1093/oncolo/oyad219
Published: 05 August 2023
Journal Article

Therapeutic Responses to Combination Nivolumab and Temozolomide as Salvage Therapy for Metastatic Melanoma: A Case Series Open Access

PDF
Rachel S Goodman and others
The Oncologist, Volume 28, Issue 9, September 2023, Pages e839–e842, https://doi.org/10.1093/oncolo/oyad184
Published: 20 June 2023
Journal Article

Recurrence of Hypophysitis After Immune Checkpoint Inhibitor Rechallenge Open Access

PDF
Benjamin C Park and others
The Oncologist, Volume 27, Issue 12, December 2022, Pages e967–e969, https://doi.org/10.1093/oncolo/oyac220
Published: 26 October 2022
Journal Article

Immune Checkpoint Inhibitors: The Unexplored Landscape of Geriatric Oncology Open Access

PDF
Khalil Choucair and others
The Oncologist, Volume 27, Issue 9, September 2022, Pages 778–789, https://doi.org/10.1093/oncolo/oyac119
Published: 04 July 2022
Journal Article

Management of Acral and Mucosal Melanoma: Medical Oncology Perspective Open Access

PDF
Seungyeon Jung and Douglas B Johnson
The Oncologist, Volume 27, Issue 8, August 2022, Pages 703–710, https://doi.org/10.1093/oncolo/oyac091
Published: 30 May 2022
Journal Article

Framework for Implementing and Tracking a Molecular Tumor Board at a National Cancer Institute–Designated Comprehensive Cancer Center Free

PDF
Neha M. Jain and others
The Oncologist, Volume 26, Issue 11, November 2021, Pages e1962–e1970, https://doi.org/10.1002/onco.13936
Published: 08 September 2021
Journal Article

Efficacy and Safety of Trametinib in Non-V600 BRAF Mutant Melanoma: A Phase II Study Free

PDF
Caroline A. Nebhan and others
The Oncologist, Volume 26, Issue 9, September 2021, Pages 731–e1498, https://doi.org/10.1002/onco.13795
Published: 04 May 2021
Journal Article

A Multicenter Analysis of Immune Checkpoint Inhibitors as Adjuvant Therapy Following Treatment of Isolated Brain Metastasis Free

PDF
J. Randall Patrinely and others
The Oncologist, Volume 26, Issue 3, March 2021, Pages e505–e507, https://doi.org/10.1002/onco.13608
Published: 08 December 2020
Journal Article

Prognostic Clinical and Radiographic Biomarkers for BRAF‐Targeted Therapy in Advanced Melanoma Free

PDF
Kaustav P. Shah and others
The Oncologist, Volume 26, Issue 2, February 2021, Pages e333–e335, https://doi.org/10.1002/onco.13562
Published: 04 November 2020
Journal Article

Immune Checkpoint Inhibitor‐Associated Primary Adrenal Insufficiency: WHO VigiBase Report Analysis Free

PDF
Virginie Grouthier and others
The Oncologist, Volume 25, Issue 8, August 2020, Pages 696–701, https://doi.org/10.1634/theoncologist.2019-0555
Published: 17 May 2020
Journal Article

The Impact of Nonsteroidal Anti‐Inflammatory Drugs, Beta Blockers, and Metformin on the Efficacy of Anti‐PD‐1 Therapy in Advanced Melanoma Free

PDF
Daniel Y. Wang and others
The Oncologist, Volume 25, Issue 3, March 2020, Pages e602–e605, https://doi.org/10.1634/theoncologist.2019-0518
Published: 29 November 2019
Journal Article

Empiric Therapy with BRAF and MEK Inhibitors in Metastatic Melanoma Free

PDF
Christopher G. Cann and others
The Oncologist, Volume 24, Issue 11, November 2019, Pages 1495–1496, https://doi.org/10.1634/theoncologist.2019-0332
Published: 18 June 2019
Journal Article

Severe Epididymo‐Orchitis and Encephalitis Complicating Anti‐PD‐1 Therapy Free

PDF
Henry T. Quach and others
The Oncologist, Volume 24, Issue 7, July 2019, Pages 872–876, https://doi.org/10.1634/theoncologist.2018-0722
Published: 01 April 2019
Journal Article

Hematologic Complications of Immune Checkpoint Inhibitors Free

PDF
Elizabeth J. Davis and others
The Oncologist, Volume 24, Issue 5, May 2019, Pages 584–588, https://doi.org/10.1634/theoncologist.2018-0574
Published: 28 February 2019
Journal Article

Impact of Age on Outcomes with Immunotherapy for Patients with Melanoma Free

PDF
Allison S. Betof and others
The Oncologist, Volume 22, Issue 8, August 2017, Pages 963–971, https://doi.org/10.1634/theoncologist.2016-0450
Published: 05 May 2017
Journal Article

Clinical Activity of Ipilimumab in Acral Melanoma: A Retrospective Review Free

PDF
Douglas B. Johnson and others
The Oncologist, Volume 20, Issue 6, June 2015, Pages 648–652, https://doi.org/10.1634/theoncologist.2014-0468
Published: 11 May 2015
Journal Article

Enabling a Genetically Informed Approach to Cancer Medicine: A Retrospective Evaluation of the Impact of Comprehensive Tumor Profiling Using a Targeted Next-Generation Sequencing Panel Free

PDF
Douglas B. Johnson and others
The Oncologist, Volume 19, Issue 6, June 2014, Pages 616–622, https://doi.org/10.1634/theoncologist.2014-0011
Published: 05 May 2014